Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1994;34(4):293-6.
doi: 10.1007/BF00686035.

Comparison of 5-fluorouracil anabolite levels after intravenous bolus and continuous infusion

Affiliations
Comparative Study

Comparison of 5-fluorouracil anabolite levels after intravenous bolus and continuous infusion

T A Stein et al. Cancer Chemother Pharmacol. 1994.

Abstract

The levels of 5-fluorouracil (5FU) and its anabolites in the serum, bile, pancreatic juice, liver, pancreas, and skeletal muscle of dogs were compared after single bolus administration and after continuous infusion. Six dogs had a bolus of 5FU (15 mg/kg) and were studied for 120 min. Five dogs had a continuous infusion of 5FU (30 mg/kg) and were studied for 24 h. After the bolus infusion, serum 5FU levels were initially high and then declined, whereas anabolite levels gradually increased over 45 min. Within 2 h, anabolite levels exceeded 5FU levels in tissues but were undetectable in bile and pancreatic juice. During the continuous infusion, anabolite levels in serum increased more rapidly than 5FU levels and remained significantly higher for 24 h. Anabolite levels also exceeded 5FU levels in bile, pancreatic juice, pancreas, and muscle but not in the liver. Continuous infusion of 5FU produced higher levels of the anabolites than did bolus infusion and maintained constant levels throughout the infusion period.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Cancer Treat Rev. 1976 Sep;3(3):141-74 - PubMed
    1. Tumori. 1990 Aug 31;76(4):385-8 - PubMed
    1. Oncology. 1989;46(4):245-50 - PubMed
    1. Eur J Surg Oncol. 1987 Aug;13(4):349-53 - PubMed
    1. Am J Surg. 1986 Feb;151(2):205-8 - PubMed

Publication types